Both in Pharmaceuticals
Fulcrum Therapeutics vs BioAge Labs
Over the past year FULC returned −59.4% and BIOA returned −6.6%; their daily moves had a correlation of 0.11.
FULC −59.4% BIOA −6.6%Growth of $1, one year, split-adjusted
| Metric | FULC | BIOA |
|---|---|---|
| Price | $3.65 | $4.84 |
| Market cap | $278.8M | $222.1M |
| Today | −0.55% | −9.53% |
| 1 month | −3.2% | −40.2% |
| 6 months | −56.0% | −73.8% |
| Year to date | −67.7% | −63.4% |
| 1 year | −62.1% | −14.9% |
| Revenue growth (YoY) | — | +1.6% |
| Gross margin | — | 100.0% |
| Net margin | — | −1064.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 21.5× |
| Net cash | $318.8M | $318.7M |
| Dividend yield | — | — |
| Volatility (60d) | 21.4% | 216.5% |
| Short % of float | 11.1% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).